Refractory Langerhans cell histiocytosis Suspended Phase 2 Trials for Erdafitinib (DB12147)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0022006 (Refractory Langerhans cell histiocytosis) | Suspended | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|
| Indication | Status | Phase |
|---|---|---|
| DBCOND0022006 (Refractory Langerhans cell histiocytosis) | Suspended | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|